Voices In Health Law

In this week’s Hlbytes Roundup, host Andrew Demetriou discusses the byte entitled “Future Coverage Trends Are in Doubt as 16 million Medicaid Enrollees Have Been Dropped” submitted by Erica Lindsay. For more on this story and others like it, go to ambar.org/hlsnews and check your inbox every Friday for the next edition of HLbytes.

In this week’s Hlbytes Roundup, host Ramana Rameswaran discusses the byte entitled “High Profile Challenges to Scope and Breadth of AKS Are Cases to Watch” submitted by Alethea M. Huyser. For more on this story and others like it, go to ambar.org/hlsnews and check your inbox every Friday for the next edition of HLbytes.

In this episode, we are joined by Johnjerica Hodge, co-chair of Katten’s ESG Risk and Investigations practice, to discuss the role ESG is playing in the healthcare sector, how healthcare companies can successfully implement or strengthen their ESG programs, and issues on her radar at the intersection of ESG and healthcare.

In this episode, we are joined by Karen Luong, a leader of Husch Blackwell’s Psychedelics & Emerging Therapies practice to discuss current research on psychedelic drugs to treat mental health disorders; the legal implications of that research and potential FDA approval; an overview of potential avenues for rescheduling under Right-to-Try laws; lessons learned from the cannabis industry; and the vi...

Join host Jeff Wurzburg and Matt Fisher for a preview of what is to come in Matt’s presentation at the 2023 Washington Health Law Summit. The presentation will provide a broad overview of the myriad uses for artificial intelligence (AI) in healthcare, including how AI can affect the healthcare industry moving forward, what AI means exactly, and how regulations will treat it. WHS is taking place De...

John Kelly of Barnes & Thornburg and Julie Nielsen of BRG preview their presentation at the 2023 ABA Managed Care Institute taking place October 11-12 in Chicago. Learn more and register for the conference at ambar.org/mci2023

Kate Driscoll (Morrison Foerster) joins to discuss the nature of clinical trials fraud, recent developments in enforcement activity and the role of lawyers in counseling compliance by clinical research organizations.

A discussion with Adrienne Dresevic, the incoming Chair of the Health Law Section on her path to leadership and plans for the upcoming year.

Join host Stephanie Dorvil as she interviews her former colleague Greg Demske, who reflects on his long legal career to becoming Chief Counsel in the Office of Counsel to the Inspector General at the Department of Health and Human Services and talks about his next chapter in private practice. This episode was recorded in March at EMI 2023.

Join host Andy Demetriou and Kimberly Chew of Husch Blackwell to discuss the emerging use of ketamine in the treatment of mental health conditions and the legal, risk and financial considerations for clinics that are integrating ketamine therapy into their practices.

Host Jeff Wurzburg interviews Kyle Brierly and Sammy Change of Athene Law about proposed rules that would make significant changes in both fee-for-service Medicaid and Medicaid managed care.

Host Jeff Wurzburg interviews Founder & CEO of FemInnovation Bethany Corbin regarding the new HIPAA proposed rules regarding reproductive health data.

Hear our host Felicia Sze (Athene Law) discuss cutting edge issues around behavioral health issues in the ED with Chris Conatser (Norton Rose Fulbright). Their discussion will cover how the behavioral health crisis is affecting healthcare providers, the causes of the crisis, areas of ambiguity in the process of providing emergency behavioral health care and creative solutions.

Join host Jeff Wurzburg and Felicia Sze (Athene Law) as they discuss the Medicaid program, the history of Medicaid managed care, how the program is funded, and current hot topics. This episode was recorded in January 2023.

Join host Stephanie Dorvil as she interviews Andrew Mahler, Vice President of Privacy and Compliance at Clearwater Compliance for insights on the evolution of privacy protections and expectations within the health care industry. Andrew’s background as a former regulator at HHS Office of Civil Rights and his in-house experience inform his thoughts and predictions for the health care industry as pri...

In this final part of the three-episode series on the Inflation Reduction Act, host Stephanie Dorvil and guest Joe Metro (Reed Smith, LLP) discuss the mechanics of the IRA’s federal drug price negotiation provisions. Under those provisions, the Department of Health and Human Services will identify a limited number of “selected drugs” each year and will negotiate a “maximum fair price” (MFP) for th...

In this second part of the three-episode series on the Inflation Reduction Act, host Stephanie Dorvil and guest Joe Metro (Reed Smith, LLP) dig deeper into the IRA’s changes to drug benefit design under Medicare Parts B and D, as well as touch on insulin cost sharing caps. And Joe shares info about a timely opportunity to comment on the inflation rebate provisions before March 11. For more info, s...

Join host Jeff Wurzburg, Beth Jacobson (Kaia Health), Nesrin Tift (Bass Berry & Sims) and Justin Chamblee (Coker Group) as they preview “How Evolutions in Digital Health are Impacting Value-Based Care,” a session at this year’s Emerging Issues in Healthcare Law Conference. This session will address how initiatives in digital health, such as artificial intelligence-enabled and information technolog...

Join host Stephanie Dorvil, Tiffany Shih (Cornerstone Research) and Elisa Long (UCLA) as they preview what the Big (Bad?) Data and the Healthcare Consumer session at this year’s Emerging Issues in Healthcare Law Conference will cover. The episode discusses predictions about how collection and analysis of health data could improve quality, lower costs and facilitate value-based care on the one hand...

Join new host Stephanie Dorvil and guest Joe Metro (Reed Smith, LLP) as they discuss the Inflation Reduction Act (IRA) in this first of a series of 3 podcast episodes on this important piece of legislation. This episode focuses on the inflation rebate provisions and their impacts on Part B and D drugs. For CMS’s info on the IRA, see: https://www.cms.gov/inflation-reduction-act-and-medicare

Join David Feniger and host Jeff Wurzburg on a discussion around the basics of Tricare. This podcast will cover the structure of the Tricare program, why it was created, how it is funded and current hot topics.

Join Kevin Milne and host Felicia Sze on a discussion around the basics of Medicare managed care, called Medicare Advantage. This podcast will cover the structure of the Medicare Advantage program, why it was created, how it was funded and current hot topics.

Join host Felicia Sze and Xavier Baker (Groom Law Group) as they discuss the background of section 1557 of the Affordable Care Act, its impacts on the civil rights protected under federal law, and recent 340B developments. This has been a saga of regulatory action since enactment and provides information on the most recent rulemaking actions important for healthcare players to know.

Join host Jeff Wurzburg and Joyce Hall (Watkins Eager) as they discuss the future of telehealth post pandemic. This is a sneak peak of Joyce’s presentation at the Washington Health Law Summit December 12-13th under the same name. To find out more about the conference and Joyce’s presentation, go to ambar.org/whs2022

Join host Andy Demetriou and Dan Avants (Husch Blackwell) as they discuss highlights of recent 340B developments for all industry stakeholders. This is a sneak peak of Dan’s presentation at the Washington Health Law Summit December 12-13th under the same name. To find out more about the conference and Dan’s presentation, go to ambar.org/whs2022